Upload File

dasatinib ( nm ) 0 0 0.1 0.5 1 5

2
Dasatinib (nM ) 0 0 0.1 0.5 1 5 M-CSF - + + + + + WB: Phospho-Erk WB: Erk WB: Phospho- Akt WB: Akt B Dasatinib (nM) 0 0 0.5 1 5 10 M-CSF - + + + + + WB: Phospho- FMSY708 WB: FMS Dasatinib (nM ) 0 0 0.1 0.5 1 5 M-CSF - + + + + + Wb: Phospho-Akt Akt Figure S1 Side scatter 0 50K100K150K200K250K 0 50K 100K 150K 200K 250K Forward scatter 0 CD14- FITC 10 2 10 3 10 4 10 5 0 40 80 120 160 200 Cell event count 88.6 C D b (nM) 0 0 0.5 1 5 10 - + + + + + WB: Phospho- FMS Y708 WB: FMS A

Upload: arsenio-marquez

Post on 02-Jan-2016

31 views

Category:

Documents


0 download

Report

DESCRIPTION

250K. 200K. Dasatinib (nM) 0 0 0.5 1 5 10 M-CSF - + + + + +. 88.6. WB: Phospho- FMS Y708 WB: FMS. 150K. 100K. 50K. 0. Dasatinib (nM) 0 0 0.5 1 5 10 - PowerPoint PPT Presentation

TRANSCRIPT

Page 1: Dasatinib ( nM ) 0 0 0.1 0.5 1 5

Dasatinib (nM ) 0 0 0.1 0.5 1 5 M-CSF - + + + + +

WB: Phospho-Erk

WB: Erk

WB: Phospho-Akt

WB: Akt

B Dasatinib (nM) 0 0 0.5 1 5 10M-CSF - + + + + + WB: Phospho- FMSY708

WB: FMS

Dasatinib (nM ) 0 0 0.1 0.5 1 5 M-CSF - + + + + +

Wb: Phospho-Akt

Akt

Figure S1Si

de s

catte

r

0 50K 100K150K200K250K 0

50K

100K

150K

200K

250K

Forward scatter0

CD14- FITC102 103 104 105

0

40

80

120

160

200

Cel

l eve

nt c

ount

88.6

C D

Dasatinib (nM) 0 0 0.5 1 5 10M-CSF - + + + + +

WB: Phospho-FMS Y708

WB: FMS

A

Page 2: Dasatinib ( nM ) 0 0 0.1 0.5 1 5

20

406080

100120

No M-CSF

0 0.5 1Imatinib (μM)

20406080

100120

0 0.5 1Imatinib (μM)

% m

acro

phag

e su

rviv

al

TA

M p

er m

m2

G H

I J

E

F


Takewaki Tsuji Lab.takewaki-lab.archi.kyoto-u.ac.jp/takewaki_tsuji_lab/pdf/...(shear strain of 0.5%) Experimental results (5mm thickness)-0.1-0.05 0 0.05 0.1-0.15-0.1-0.05 0 0.050.10.15

Hidráulica industrial. Oleohidráulica industrial · intercambiadores para medidas ver catalogo en: øg calor motor 0. 05 kw 0. 0. 0 .07 kw 07 0.1 kw (3.25 kw 0.07 0.1 0.1 kw 0.1

Annual Summary of - Columbus, Ohio · 2010. 8. 18. · Cryptosporidiosis 17 1.6 27 2.4 313 27.7 Cytomegalovirus 1 0.1 5 0.4 1 0.1 Dengue 1 0.1 0 0.0 0 0 Diphtheria 0 0.0 0 0.0 0 0

SPRYCEL (dasatinib) tablets label

Dasatinib BMS-354825 - Spirit 2spirit-cml.org/isf/referencesafetyinformation/1.2 Dasatinib RSI... · Section Change Section 1: ... Dasatinib BMS-354825 Investigator Brochure Summary

CHAPTER 0 EXECUTIVE SUMMARY 0.1 Introduction

Monetary Policy Regimes and Capital Account€¦ · 0 5 10 15 20 0 0.05 0.1 0.15 0.2 Real GDP Percent deviations 0 5 10 15 20-0.3-0.2-0.1 0 0.1 Domestic inflation Benchmark Hawkish

HOMO LUMO Analysis of Dasatinib · LUMO analysis for Dasatinib was conducted byB3LYP/6-31G (d, p) level of theory. The gaps between Homo & Lumo of Dasatinib is 4.33259894eV.Similarly

§0 Historie, Überblick, Grafik-Software 0.1 Historiedannen/HTW_Vorlesung/Kapitel00.pdf · §0-3 §0 Historie, Überblick, Grafik-Software Computergrafik - SS 2004 0.1 Historie Anwendungs-

Dasatinib OSA paper

Sprycel, INN: dasatinib - Europa

0123$4566789:; !#$%&'()*+,-(./!0.1 2(3456'2( !#$%&'()*#+, · !"#$%&'()*+,-./0123$4566789:;!"#$%&'()*+,-(./!0.1 2(3456'2(!"#$%&#'()*#+, -./012&34!"#$%&"'()*+#,-*+."/0"12#3456789!"#$%&'()*+,-&./0,'12345%&6/789

QCon London · r bingo ! I 2 1 1 0 1 1 0 0 1 1 •SVD •Word2vec word f1 f2 f3 f4 f5 dog 0.8 0.2 0.1-0.1-0.4 this -0.2 0 0.1 0.8 0.3 love 0.1 0.2 0.7-0.50.1 cute 0.2 0.2 0.8-0.4

Oscillator JT33(V) · (VC)TCXO RoHS · 2# 1 # 3 # 4 2. 5 ±0.1 5 3.2±0.15 1.0 max. 1. 0 ±0.1 0.75 ±0 1.2±0.1 1.3 ±0.1 1. 1 ±0 0.8 .1 ±0.1 1.0±0.1 1# 2 # 4 3 1.0±0.1 Oscillator

AUSTRALIAN PRODUCT INFORMATION – SPRYCEL (DASATINIB) · AUSTRALIAN PRODUCT INFORMATION – SPRYCEL® (DASATINIB) 1 NAME OF THE MEDICINE Dasatinib 2 QUALITATIVE AND QUANTITATIVE

Dasatinib + Gefitinib, a non platinum-based combination

0.1 0.2 0 - Gotop

Yellowstone National Park Emergency Dial 911 Park ... Mi 0.5 Km 0 0 0.5 Mi 0.5 Km 0 0.5 Km 0 0.1 0 0.1 0.4 Mi 0 0.1 0.4 Km 0.5 Mi 0.5 Km North North North North 89 20 287 287 191 191

$0&)1)'&*1 2*0.1$3 .#$/&,& 4$ *5#* - )( 65$ · $0&)1)'&*1 2*0.1$3 .#$/&,& 4$ *5#* - )( 65$ ... *""5#*"- =

Working Paper - Bank Indonesia · 31 0 48-0.1 0 0.1 USGBY 0 48-10-5 0 5 x 10-3 Indonesia Y 0 48-0.01 0 0.01 Indonesia DP 0 48-5 0 5 10 x 10-3Indonesia EP 0 48-0.1 0 0.1 Indonesia

Dasatinib as a Probable Cause of Bilateral Chylothorax in ... · chylothorax most probable secondary to dasatinib. Discussion Dasatinib is a potent second-generation TKI frequently

0 00 0 ---- GLAVNA SVESKAGLAVNA SVESKAGLAVNA SVESKA - … · 0.1. naslovna stranaglavne sveske tehni^ke 0.1. naslovna strana glavne sveske tehni^ke dokumentacijedokumentacije 0 00

Dasatinib-Induced Pulmonary Arterial Hypertension Treated ...Case Report Dasatinib-Induced Pulmonary Arterial Hypertension Treated with Upfront Combination Therapy Makoto Nishimori

0 %&$&'()*+,-+)'&$ .*+.-,%+*#+&$,$/,$ 0.1,-,%+.#$/.$2.'+.$$

Stan: A platform for Bayesian inferencegelman/presentations/stantalk... · 2014. 11. 14. · 33/44 NUTSExampleTrajectory Hoffman and Gelman!0.1 0 0.1 0.2 0.3 0.4 0.5!0.1 0 0.1 0.2

Fast Pattern Detection using Orbit Decomposition · rotation of 2D signal projected into its 3 highest eigen-vectors-0.2-0.15-0.1-0.05 0 0.05 0.1 0.15-0.2-0.1 0 0.1 0.2 0.3-0.2-0.15-0.1-0.05

Dasatinib 302962-49-8-api-manufacturer-suppliers

Einfluss von Dasatinib auf die Expansion, Zytotoxizität ... · 3.1.2 Dasatinib erhöht nicht die Gesamttodesrate von NK-Zellen ..... 29 3.1.3 Expansion der NK-Zellen unter Dasatinib

 · intercambiadores para medidas ver catalogo en: øg calor motor 0. 05 kw 0. 0. 0 .07 kw 07 0.1 kw (3.25 kw 0.07 0.1 0.1 kw 0.1

Starting on SPRYCEL (dasatinib)

KIT pathway upregulation predicts dasatinib efficacy in

SigProc 6-FIR.ppt [Kompatibilitätsmodus]...b = [0 1[0.1 030.3 050.5 030.3 01]0.1] H()zzzzz=+ + + +0.1 0.3 0.5 0.3 0.1−− − −12 3 4 0 10 dB) 0.5 1 y Part 0 02 04 06 08 1-30-20

879:9;

*/ 0.1 0%+*Ï *1 - Vaisala

servlet.FileDownload · Folium Biosciences CERTIFICATE OF INTERNAL ANALYSIS Wt. (0/0) < 0.1 < 0.1 < 0.1 < 0.1 < 0.1 < 0.1 < 0.1 < 0.1 < 0.1 < 0.1 < 0.1 < 0.1 < 0.1 TYPE: Cellulose